Evidence map›Paper›PMID 40085171›Full record

ArticleMolecular imaging and biology2025

Development of Anti-CEA C

Jitender Jitender, Teresa Hong, Anakim Sherman, Patty Wong, Eric Aniogo, Maciej Kujawski, John E Shively, Paul J Yazaki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jitender JitenderDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
Teresa HongDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
Anakim ShermanDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
Patty WongDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
Eric AniogoDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
Maciej KujawskiDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
John E ShivelyDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA.
Paul J YazakiDepartment of Immunology and Theranostics, Beckman Research Institute, City of Hope, USA. pyazaki@coh.org.ORCID http://orcid.org/0000-0003-2626-3303

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRecombinant antibody fragments represent a novel class of in vivo biological immunoPET imaging agents. This study developed a series of anti-carcinoembryonic antigen (CEA) C PROCEDURE: A series of humanized anti-CEA M5A∆C

resultsThe anti-CEA M5A∆C

conclusionsA series of humanized anti-CEA M5A∆C

Indexed as

Carcinoembryonic AntigenColorectal NeoplasmsPositron-Emission TomographyAnimalsCell Line, TumorCopper RadioisotopesFemaleHumansMiceMice, NudeProtein DomainsTissue DistributionCarcinoembryonic AntigenCopper RadioisotopesAntibody engineeringAnti-CEA antibodyColorectal cancerImmunoPET imagingRadiodiagnostics

Identifiers

PMID40085171
PMCPMC12062029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.